Concourse Financial Group Securities’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5482 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6346 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6340 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6359 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6356 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6287 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6153 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6008 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5791 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5787 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5608 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5585 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5480 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5485 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5335 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5163 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5015 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4884 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4687 |
|